Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 12 of 325 for:    ibrutinib

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03229200
Recruitment Status : Enrolling by invitation
First Posted : July 25, 2017
Last Update Posted : December 9, 2019
Sponsor:
Information provided by (Responsible Party):
Pharmacyclics Switzerland GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : July 2, 2027
Estimated Study Completion Date : July 2, 2027